ACRC Trials
ACRC Trials is a clinical research organization dedicated to advancing medical science through conducting clinical trials across various health conditions, including alopecia, gout, vaccine development, and weight loss. They focus on providing innovative treatment options, community engagement, and contributing to public health efforts, especially in Texas.
Industries
Nr. of Employees
small (1-50)
ACRC Trials
Products
Androgenic alopecia clinical study (male pattern hair loss)
Multi-center, randomized, double-blind, placebo-controlled oral tablet study in males aged 18–65 to evaluate safety and efficacy of a non-hormonal investigational treatment for pattern hair loss; includes 13 visits over ~12 months and a 6-month treatment extension.
Chronic gout clinical study (tophi reduction focus)
Clinical study evaluating therapies aimed at reducing tophi burden and managing chronic gout symptoms for participants not adequately controlled on standard care; recruitment and study details provided to potential participants.
Vaccine clinical trial programs
Enrollment and conduct of vaccine trials including COVID-19, COVID boosters, influenza, RSV, norovirus, and urinary tract infection vaccine candidates with safety monitoring and immunogenicity assessment.
Weight loss clinical study (GLP-1/GIP-based therapies)
Study evaluating combination GLP-1 and GIP-based pharmacotherapies for weight loss in adults with BMI ≥27, including screening, laboratory assessments, and ongoing monitoring; participants may receive compensation and no-cost study care.
Androgenic alopecia clinical study (male pattern hair loss)
Multi-center, randomized, double-blind, placebo-controlled oral tablet study in males aged 18–65 to evaluate safety and efficacy of a non-hormonal investigational treatment for pattern hair loss; includes 13 visits over ~12 months and a 6-month treatment extension.
Chronic gout clinical study (tophi reduction focus)
Clinical study evaluating therapies aimed at reducing tophi burden and managing chronic gout symptoms for participants not adequately controlled on standard care; recruitment and study details provided to potential participants.
Vaccine clinical trial programs
Enrollment and conduct of vaccine trials including COVID-19, COVID boosters, influenza, RSV, norovirus, and urinary tract infection vaccine candidates with safety monitoring and immunogenicity assessment.
Weight loss clinical study (GLP-1/GIP-based therapies)
Study evaluating combination GLP-1 and GIP-based pharmacotherapies for weight loss in adults with BMI ≥27, including screening, laboratory assessments, and ongoing monitoring; participants may receive compensation and no-cost study care.
Services
Pre-screening, medical screening visits, eligibility assessment, and scheduling for enrollment into ongoing clinical studies.
Operational execution of study visits, administration of investigational products or placebo, safety monitoring, and data collection per protocol.
Referral-based participant outreach with financial incentivization for successful referrals and assistance completing enrollment processes.
Pre-screening, medical screening visits, eligibility assessment, and scheduling for enrollment into ongoing clinical studies.
Operational execution of study visits, administration of investigational products or placebo, safety monitoring, and data collection per protocol.
Referral-based participant outreach with financial incentivization for successful referrals and assistance completing enrollment processes.
Expertise Areas
- Clinical trial management
- Vaccine clinical research
- Participant recruitment and retention
- Dermatology clinical trials (alopecia)
Key Technologies
- Randomized double-blind placebo-controlled trial design
- Phase I–IV clinical trial frameworks
- Oral small-molecule investigational therapeutics
- GLP-1 and GIP-based pharmacotherapy evaluation